Posters

Search Title by author or title

Early results with the EyeCryl phakic toric intraocular lens implantation in keratoconus patients

Poster Details

First Author: K.Balparda COLOMBIA

Co Author(s):    C. Vanegas-Ramírez   T. Herrera-Chalarca   L. Silva-Quintero   .            

Abstract Details

Purpose:

To describe refractive, visual and complications results after 6-months following of keratoconus patients implanted with an EyeCryl Phakic Toric intraocular lens in at least one of their eyes.

Setting:

Private practice hospital, located in Medellín, Colombia

Methods:

This is a retrospective chart review study, including all keratoconus patients implanted with an EyeCryl Phakic Toric intraocular lens in at least one of their eyes by an experienced cornea surgeon in Colombia. All patients were evaluated for their uncorrected and corrected distance visual acuity (UDVA and CDVA, respectively), their spherical equivalent, their endothelial cell count, and their clinical appearance of complications.

Results:

A total of 20 eyes belonging to 14 patients were included, with an average age of 29.3 ± 4.2 years. Spherical equivalent improved from a pre-surgical value of –10.31 D to +0.09 D at 6 months. 65% of the patients improved at least one line in the best-corrected distance visual acuity. At 6 months, 70% of patients were within ±0.50 D of spherical equivalent emmetropia. Endothelial cell count remained stable. No complications occurred in any of the patients.

Conclusions:

EyeCryl Phakic Toric intraocular lens implantation is a safe, effective and predictable intervention for refractive improvement in keratoconus patients. Results are stable through at least 6 months after surgery. This is, to the authors knowledge, the very first study to evaluate the results of this brand of lenses in the keratoconus population.

Financial Disclosure:

receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented, travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented

Back to Poster listing